Skip to main content
Log in

A population-based study of the extent of surgical resection of potentially curable colon cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

We attempted to determine factors contributing to the extent of initial curative resection for colon cancer in a population-based cohort. Total abdominal colectomy with ileorectal anastomosis (TAC-IR) may be considered for young patients or those with a colorectal cancer family history to prevent metachronous lesions and facilitate surveillance.

Methods

All Ontario patients newly diagnosed with colon cancer over 12 months beginning in July 1997 were staged at the time of surgery. The extent of resection was compared with variables, including familial risk obtained from the Ontario Familial Colon Cancer Registry.

Results

Complete staging was possible for 86% of patients. A total of 1223 patients had a potentially curative resection: 17%, 46%, and 36% were stage I, II, and III, respectively. Patients were more likely to receive a TAC-IR if they were ≤50 years old (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.8–6.6), if they had a synchronous lesion (OR, 28.37; 95% CI, 12.2–61.2), or if they were at a teaching hospital (OR, 2.8; 95% CI, 1.6–4.7), but not if they had a family history (OR, 7; 95% CI, 3–1.5).

Conclusions

Young age, teaching hospital, and multiple cancers but not family history were important factors for performing a TAC-IR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Terdiman JP, Conrad PG, Sleisenger MH. Genetic testing in hereditary colorectal cancer: indications and procedures.Am J Gastroenterol 1999;94:2344–56.

    Article  PubMed  CAS  Google Scholar 

  2. Burke W, Petersen GM, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, I. Hereditary nonpolyposis colon cancer.JAMA 1997;277: 915–9.

    Article  PubMed  CAS  Google Scholar 

  3. Mecklin JP, Jarvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma.Dis Colon Rectum 1993;36:927–9.

    Article  PubMed  CAS  Google Scholar 

  4. Lynch HT, Lynch JF. Hereditary nonpolyposis colorectal cancer.Semin Surg Oncol 2000;18:305–13.

    Article  PubMed  CAS  Google Scholar 

  5. Guillem JG, Puig-La Calle J, Cellini C, et al. Varying features of early age-of-onset “sporadic” and hereditary nonpolyposis colorectal cancer patients.Dis Colon Rectum 1999;42:36–42.

    Article  PubMed  CAS  Google Scholar 

  6. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willet WC. A prospective study of family history and the risk of colorectal cancer.N Engl J Med 1994;331:1669–74.

    Article  PubMed  CAS  Google Scholar 

  7. Ries LAG, Eisner MP, Kosary CL, et al, eds.SEER Cancer Statistics Review 1973–1997, Bethesda, MD: National Cancer Institute, 2000.

    Google Scholar 

  8. Hall NR, Finan PJ, Ward B, Turner G, Bishop DT. Genetic susceptibility to colorectal cancer in patients under 45 years of age.Br J Surg 1994;81:1485–9.

    Article  PubMed  CAS  Google Scholar 

  9. Guillem JG, Bastar AL, Ng J, Huhn JL, Cohen AM. Clustering of colorectal cancer in families of probands under 40 years of age.Dis Colon Rectum 1996;39:1004–7.

    Article  PubMed  CAS  Google Scholar 

  10. Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population.Int J Cancer 1996;68:428–35.

    Article  PubMed  CAS  Google Scholar 

  11. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).Dis Colon Rectum 1991;34:424–5.

    Article  PubMed  CAS  Google Scholar 

  12. Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer.Ann Med 1996;28:479–82.

    PubMed  CAS  Google Scholar 

  13. Syngal S, Fox EA, Li C, et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.JAMA 1999;282:247–53.

    Article  PubMed  CAS  Google Scholar 

  14. Genuardi M, Anti M, Capozzi E, et al. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer.Int J Cancer 1998;75:835–9.

    Article  PubMed  CAS  Google Scholar 

  15. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.N Engl J Med 1998;339:511–8.

    Article  PubMed  CAS  Google Scholar 

  16. Beck NE, Tomlinson IP, Homfray T, Hodgson SV, Harocopos CJ, Bodmer WF. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled.Br J Surg 1997;84:233–7.

    Article  PubMed  CAS  Google Scholar 

  17. Madlensky L, Berk TC, Bapat BV, et al. A preventive registry for hereditary nonpolyposis colorectal cancer.Can J Oncol 1995;5: 355–60.

    PubMed  CAS  Google Scholar 

  18. Bapat BV, Madlensky L, Temple LK, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.Hum Genet 1999; 104:167–76.

    Article  PubMed  CAS  Google Scholar 

  19. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.Gastroenterology 1999;126:1453–6.

    Article  Google Scholar 

  20. Haile RW, Siegmund KD, Gauderman WJ, Thomas DC. Studydesign issues in the development of the University of Southern California Consortium’s Colorectal Cancer Family Registry.J Natl Cancer Inst Monogr 1999;26:89–93.

    PubMed  Google Scholar 

  21. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria teria for the determination of microsatellite instability in colorectal cancer.Cancer Res 1998;58:5248–57.

    PubMed  CAS  Google Scholar 

  22. Cali RL, Pitsch RM. Cumulative incidence of metachronous colorectal cancer.Dis Colon Rectum 1993;36:388–93.

    Article  PubMed  CAS  Google Scholar 

  23. Demeter JG, Freeark RJ. The role of prophylactic subtotal colectomy in metachronous carcinoma of the colon and rectum.Surg Gynecol Obstet 1992;175:1–7.

    PubMed  CAS  Google Scholar 

  24. Svendsen LB, Bulow S, Mellemgaard A. Metachronous colorectal cancer in young patients: expression of the hereditary nonpolyposis colorectal cancer syndrome?Dis Colon Rectum 1991;34:790–3.

    Article  PubMed  CAS  Google Scholar 

  25. Stern HS. Contributions of molecular genetics to the clinical management of colorectal cancer.Am J Surg 1996;171:10–5.

    Article  Google Scholar 

  26. Brief DK, Brener BJ, Goldenkraz R, et al. Defining the role of subtotal colectomy in the treatment of carcinoma of the colon.Ann Surg 1991;213:248–52.

    Article  PubMed  CAS  Google Scholar 

  27. Berk T, Cohen Z. The inherited colorectal cancer registry: families are our patients. In: Schrock TR, ed.Perspectives in Colon and Rectal Cancer Surgery. 12th ed. New York: Thieme, 1999:1–12.

    Google Scholar 

  28. Cotterchio M, McKeown-Eyssen G, Sutherland H, et al. Ontario Familial Colon Cancer Registry: methods and first-year response rates.Chronic Dis Can 2000;21:81–6.

    PubMed  CAS  Google Scholar 

  29. American Joint Committee on Cancer. Colon and rectum. In:AJCC Cancer Staging Manual. 5th ed. Philadelpha: Lippincott-Raven, 1997:95–8.

    Google Scholar 

  30. Arbman G, Nilsson E, Storgren-Fordell V, Sjordahl R. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1986.Dis Colon Rectum 1995;38:645–50.

    Article  PubMed  CAS  Google Scholar 

  31. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.N Engl J Med 1998;338:1481–7.

    Article  PubMed  CAS  Google Scholar 

  32. Evans DG, Walsh S, Jeacock J, et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer.Br J Surg 1997;84: 1281–5.

    Article  PubMed  CAS  Google Scholar 

  33. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.J Clin Oncol 2000;18:2193–200.

    PubMed  CAS  Google Scholar 

  34. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy.Ann Surg 1997;225:202–7.

    Article  PubMed  CAS  Google Scholar 

  35. McLaughlin J, Sloan M, Janovjak D.Cancer survival in Ontario. Toronto: Ontario Cancer Treatment and Research Foundation, 1995.

    Google Scholar 

  36. Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF. The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario.J Clin Epidemiol 2001; 54:93–8.

    Article  PubMed  CAS  Google Scholar 

  37. King WD, Marrett LD, Woolcott CG. Case-control study of colon and rectal cancers and chlorination by-products in treated water.Cancer Epidemiol Biomarkers Prev 2000;9:813–8.

    PubMed  CAS  Google Scholar 

  38. Kampman E, Slattery ML, Bigler J, et al. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study.Cancer Epidemiol Biomarkers Prev 1999;8:15–24.

    PubMed  CAS  Google Scholar 

  39. Le Marchand L, Wilkens LR, Hankin JH, Kolonel LN, Lyu LC. Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention.Cancer Epidemiol Biomarkers Prev 1999;8:45–51.

    PubMed  Google Scholar 

  40. Soravia C, Klein L, Berk T, O’Connor BI, Cohen Z, McLeod RS. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis.Dis Colon Rectum 1999;42:1028–33.

    Article  PubMed  CAS  Google Scholar 

  41. Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E. Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polysis.Dis Colon Rectum 1996;39:1404–8.

    Article  PubMed  CAS  Google Scholar 

  42. Gordon PH, Nivatvongs S, eds.Principles and Practice of Surgery for the Colon, Rectum, and Anus. 2nd ed. St Louis: Quality Medical Publishing, 1999.

    Google Scholar 

  43. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. The SCOTIA Study Group. Subtotal colectomy versus on-table irrigation and anastomosis.Br J Surg 1995;82:1622–7.

  44. Eu KW, Lim SL, Seow-Choen F, Leong AF, Ho YH. Clinical outcome and bowel function following total abdominal colectomy and ileorectal anastomosis in the Oriental population.Dis Colon Rectum 1998;41:215–8.

    Article  PubMed  CAS  Google Scholar 

  45. Heriot AG, Murday V, Kumar D. Screening relatives of patients with colorectal cancer: the need for continuing education.J R Coll Surg Edinb 1999;44:13–5.

    PubMed  CAS  Google Scholar 

  46. Brueckl WM, Limmert T, Brabletz T. Mismatch repair deficiency in sporadic synchronous colorectal cancer.Anticancer Res 2000; 20:4727–32.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexandra M. Easson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Easson, A.M., Cotterchio, M., Crosby, J.A. et al. A population-based study of the extent of surgical resection of potentially curable colon cancer. Annals of Surgical Oncology 9, 380–387 (2002). https://doi.org/10.1007/BF02573873

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573873

Key Words

Navigation